Shares of EUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report) passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $14.87 and traded as high as $15.69. EUDA Health shares last traded at $15.56, with a volume of 21,385 shares changing hands.
Analysts Set New Price Targets
EUDA has been the subject of a number of recent analyst reports. Wall Street Zen raised shares of EUDA Health to a “hold” rating in a research report on Saturday, October 17th. Weiss Ratings restated a “sell (e+)” rating on shares of EUDA Health in a research report on Tuesday, November 3rd. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, EUDA Health currently has a consensus rating of “Hold” and an average target price of $55.00.
Check Out Our Latest Research Report on EUDA Health
EUDA Health Trading Down 1.6%
EUDA Health (NASDAQ:EUDA – Get Free Report) last issued its quarterly earnings results on Tuesday, September 29th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.57). The business had revenue of $1.73 million during the quarter, compared to analysts’ expectations of $9.61 million.
EUDA Health Company Profile
EUDA Health Limited (NASDAQ: EUDA) is a digital health company focused on improving access to healthcare through technology-enabled services. The company’s activities center on virtual care and healthcare platforms designed to connect patients with providers and support the delivery of convenient, digitally enabled medical services. EUDA Health’s offerings include telehealth and other digital healthcare solutions, with an emphasis on behavioral and mental health services. Its platforms are intended to help patients access care remotely while supporting healthcare professionals with tools for communicating with and managing patients.
See Also
- Five stocks we like better than EUDA Health
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.
